Prostarm grants 3.21 lakh ESOPs at Rs.50 each

1 min read     Updated on 22 May 2026, 09:11 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Prostarm Info Systems Limited granted 3,21,750 stock options at Rs.50 per share under ESOP 2024. The options vest per specific conditions with no lock-in on exercised shares.

powered bylight_fuzz_icon
41010086

*this image is generated using AI for illustrative purposes only.

Prostarm Info Systems Limited has approved the grant of 3,21,750 Employee Stock Options to an eligible employee, including those of a subsidiary company. The decision was made by the company's Nomination and Remuneration Committee during its meeting on May 22, 2026, under the 'Prostarm Employee Stock Option Plan 2024' (ESOP 2024).

The options granted correspond to 3,21,750 equity shares of Rs.10 each. The exercise price for these options has been fixed at Rs.50 per share. The scheme is compliant with the Securities and Exchange Board of India (SBEB) Regulations, 2014, and the SEBI (SBEBSE) Regulations, 2021.

Key Details of the Grant

The following table outlines the specific details regarding the grant of options:

Particulars Details
Options Granted 3,21,750
Shares Covered 3,21,750 equity shares of Rs.10 each
Exercise Price Rs.50 per option
Vesting Period As per grant letter and ESOP 2024
Exercise Period Within 1 year from date of vesting

Terms and Conditions

The options granted will vest in accordance with the conditions specified in the grant letter and the ESOP 2024. There is no lock-in period applicable to the equity shares arising from the exercise of these options. Once allotted, these shares will rank pari-passu with existing equity shares of the company.

In the event of corporate actions such as a rights issue, bonus issue, sub-division, consolidation, or merger, the company will make reasonable adjustments to the number of options and/or the exercise price as per the provisions of ESOP 2024.

Historical Stock Returns for Prostarm Info Systems

1 Day5 Days1 Month6 Months1 Year5 Years
+2.47%+1.78%-11.41%-21.15%+23.62%+12.38%

How might the Rs.50 exercise price compare to Prostarm Info Systems' prevailing market price, and what does this discount (or premium) signal about management's confidence in future stock performance?

Could this ESOP grant be a precursor to Prostarm Info Systems pursuing aggressive talent acquisition or retention strategies ahead of a major business expansion or product launch?

How will the potential dilution from 3,21,750 new equity shares impact existing shareholders' ownership percentage and earnings per share if all options are exercised?

like17
dislike

Prostarm Info Systems Submits Revised Monitoring Agency Report for Q4 FY2025-26 Under SEBI Regulation 32

4 min read     Updated on 14 May 2026, 12:58 PM
scanx
Reviewed by
Shraddha JScanX News Team
AI Summary

Prostarm Info Systems Limited submitted a revised Monitoring Agency Report for Q4 FY2025-26, covering IPO proceeds of INR 168.000 Cr. raised during May 27–29, 2025. As at March 31, 2026, INR 155.517 Cr. had been utilized across working capital, debt repayment, general corporate purposes, and issue expenses, with INR 12.483 Cr. remaining unutilized against the inorganic growth object. The unutilized funds are currently held in fixed deposits with ICICI Bank, earning a total of INR 0.025 Cr. The Monitoring Agency, Acuité Ratings and Research Limited, confirmed no material deviation from the objects of the issue, while noting a 43-day delay in the inorganic growth objective. The company has proposed redeployment of the unutilized funds towards working capital requirements, subject to shareholder approval.

powered bylight_fuzz_icon
40289266

*this image is generated using AI for illustrative purposes only.

Prostarm Info Systems Limited has filed a revised Monitoring Agency Report for the quarter ended March 31, 2026 (Q4 FY2025-26), pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was prepared by Acuité Ratings and Research Limited, the appointed Monitoring Agency, to oversee the utilization of proceeds from the company's Initial Public Offering. The company clarified that the revised submission was necessitated by the inadvertent attachment of an unsigned copy in the earlier intimation, and that the contents of the report remain unchanged.

IPO Issue Overview

The company, which operates in the Other Electrical Equipment / Capital Goods sector, conducted its public issue during May 27, 2025 to May 29, 2025. The key details of the issue are summarized below:

Parameter: Details
Issue Period: May 27, 2025 to May 29, 2025
Type of Issue: Public Issue
Type of Securities: Equity Shares
Issue Size: INR 168.000 Cr.
Monitoring Agency: Acuité Ratings and Research Limited

Utilization of IPO Proceeds

The Monitoring Agency reviewed the deployment of IPO proceeds across all stated objects as at the end of Q4 FY2025-26. The report indicates that the majority of funds have been fully utilized, with one object remaining pending. The following table captures the progress in utilization:

Item Head: Amount Proposed [INR Cr.] Amount Raised [INR Cr.] Utilized at End of Quarter [INR Cr.] Unutilized [INR Cr.]
Funding working capital requirements: 72.500 72.500 72.500 Nil
Prepayment/repayment of outstanding borrowings: 17.958 17.958 17.958 Nil
Inorganic growth through unidentified acquisitions & strategic initiatives: 12.483 12.483 - 12.483
General Corporate Purposes: 42.000 42.000 42.000 Nil
Issue Expense: 23.059 23.059 23.059 Nil
Total: 168.000 168.000 155.517 12.483

General Corporate Purpose Utilization

The INR 42.000 Cr. allocated under General Corporate Purposes was fully utilized by the end of the quarter. The breakdown of its deployment is as follows:

Item Head: Amount [INR Cr.]
For Working Capital: 28.81
For Capacity Expansion: 13.19
Total: 42.000

The Monitoring Agency confirmed that the company had fully utilized the funds allocated towards these objects.

Delay in Inorganic Growth Object and Deployment of Unutilized Funds

A delay of 43 days (as on the Monitoring Agency report date) was noted in the implementation of the inorganic growth object, which had a completion date of March 31, 2026, as per the offer document. The object is yet to start. The Board of Directors stated that despite a detailed evaluation of domestic and international acquisition opportunities, no opportunity was identified that met the company's desired strategic and financial parameters, resulting in the temporary non-utilization of these funds.

The INR 12.483 Cr. in unutilized proceeds has been deployed in fixed deposits, as detailed below:

Instrument & Account: Amount Invested [INR Cr.] Maturity Date Earning [INR Cr.] Return on Investment (%) Market Value at End of Quarter [INR Cr.]
Fixed Deposit – ICICI Bank (280213015400): 5.403 09-12-2026 0.011 6.25 5.51
Fixed Deposit – ICICI Bank (280213015399): 6.000 09-12-2026 0.012 6.25 6.12
Fixed Deposit – ICICI Bank (280213015413): 1.080 11-06-2027 0.002 6.40 1.10
Total: 12.483 0.025 12.73

The company's management has proposed redeployment of the unutilized IPO proceeds towards funding working capital requirements and is in the process of seeking requisite shareholder approval for the same. The Board noted that any future inorganic growth or strategic opportunities will be considered for funding through internal accruals or other permissible sources.

Monitoring Agency Findings

The Monitoring Agency, Acuité Ratings and Research Limited, confirmed that no material deviation from the objects of the issue was observed, and no change in the means of finance was noted. Key findings from the compliance review are summarized below:

  • Deviation from objects: No deviation observed
  • Material deviation requiring shareholder approval: Not applicable
  • Change in means of finance: No change observed
  • Favorable/unfavorable events affecting viability: None observed
  • Government/statutory approvals: Not required for the stated objects
  • Information materially affecting investor decision-making: None evident

The report was signed by Vikas Mishra, Deputy Vice President – Process Excellence, Acuité Ratings and Research Limited, and submitted on behalf of Prostarm Info Systems by Sachin Gupta, Company Secretary and Compliance Officer (Membership No: F12500).

Historical Stock Returns for Prostarm Info Systems

1 Day5 Days1 Month6 Months1 Year5 Years
+2.47%+1.78%-11.41%-21.15%+23.62%+12.38%

Will Prostarm Info Systems successfully secure shareholder approval to redeploy the INR 12.483 Cr. towards working capital, and what timeline is expected for this resolution?

Given the 43-day delay in identifying suitable acquisition targets, how might Prostarm's inorganic growth strategy evolve, and could the company revisit this objective in future fundraising plans?

How will the full utilization of INR 72.500 Cr. towards working capital requirements impact Prostarm's revenue growth and operational capacity in FY2026-27?

like20
dislike

More News on Prostarm Info Systems

1 Year Returns:+23.62%